Tang XY, Zheng W, Ding M, Guo KJ, Yuan F, Feng H, . . . Gao L. (2016). miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism. Dove Medical Press.
Chicago Style (17th ed.) CitationTang XY, et al. MiR-125b Acts as a Tumor Suppressor in Chondrosarcoma Cells by the Sensitization to Doxorubicin Through Direct Targeting the ErbB2-regulated Glucose Metabolism. Dove Medical Press, 2016.
MLA (9th ed.) CitationTang XY, et al. MiR-125b Acts as a Tumor Suppressor in Chondrosarcoma Cells by the Sensitization to Doxorubicin Through Direct Targeting the ErbB2-regulated Glucose Metabolism. Dove Medical Press, 2016.
Warning: These citations may not always be 100% accurate.